Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Alaska Permanent Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 19
Average round size
info
The average size of a deal this fund participated in
$180M
Portfolio companies 11
Rounds per year 0.40
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 4
Key employees 4
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Medical
  • Farming
  • Agriculture
Summary

Alaska Permanent Fund is the famous VC, which was founded in 1976. The main office of represented VC is situated in the Juneau. The company was established in North America in United States.

Opposing the other organizations, this Alaska Permanent Fund works on 7 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2017. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from Alaska Permanent Fund is more than 1 billion dollars. The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2017.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Alaska Permanent Fund, startups are often financed by Flagship Pioneering, ARCH Venture Partners, Fidelity Management and Research Company. The meaningful sponsors for the fund in investment in the same round are Flagship Pioneering, ARCH Venture Partners, Yukon Partners. In the next rounds fund is usually obtained by Flagship Pioneering, Baillie Gifford, Venrock.

We can highlight the next thriving fund investment areas, such as Therapeutics, IaaS. Among the most popular portfolio startups of the fund, we may highlight Juno Therapeutics, Indigo Agriculture, Denali Therapeutics. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 1 or 4 of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The overall number of key employees were 4.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Alaska Permanent Fund:
Typical Co-investors
Alaska Permanent Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Alaska Permanent Fund:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Batu Capital New York, New York, United States
Cascade Seed Fund Bend, Oregon, United States
Costella Kirsch California, Menlo Park, United States
Disruptive Labs California, Santa Monica, United States
Domo Investment Chengdu, China, Sichuan
eGuarantee Japan, Tokyo
Fraser Mackenzie Canada, Ontario, Toronto
Furui Caizhi Guquan Jijin China, Jiangsu, Nanjing
Kendu Partners Company -
MedScience Ventures -
Padberg & Partners New York, New York, United States
Princeton Biopharma Capital Partners New York, New York, United States
SMBC Nikko Securities Japan -
Sprint Kansas, Overland Park, United States
Taiho Pharmaceutical Co Japan, Tokyo
Wanxiang America Elgin, Illinois, United States
Xinrong Voyage Fund -
Yike Zongheng Beijing, Beijing, China
ZeroDotNet -
Zhejiangsheng Chanye Jijin China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ryne Biotechnology

Biotechnology
Health Care
Medical
$82M29 Feb 2024 Cambridge, Massachusetts, United States

Generate Biomedicines

Biotechnology
$370M18 Nov 2021 Pennsylvania, United States

Repertoire Immune Medicines

Biotechnology
Life Science
Medical
Therapeutics
$189M13 Apr 2021 Cambridge, Massachusetts, United States

Tessera Therapeutics

Biopharma
Biotechnology
Therapeutics
$230M12 Jan 2021 Cambridge, Massachusetts, United States

Sana Biotechnology

Biotechnology
Health Care
Life Science
Product Research
$700M23 Jun 2020 Seattle, Washington, United States

Codiak Biosciences

Biotechnology
Medical
Therapeutics
$76M29 Nov 2017 San Francisco, California, United States

Generate Capital

Financial Services
Renewable Energy
Solar
Sustainability
$200M24 Oct 2017 San Francisco, California, United States

Denali Therapeutics

Biotechnology
Genetics
Health Diagnostics
Therapeutics
$130M25 Aug 2016 San Francisco, California, United States

Indigo

Agriculture
AgTech
Farming
GreenTech
$100M21 Jul 2016 Boston, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Alaska Permanent Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 19
Average round size 180M
Rounds per year 0.40
Peak activity year 2021
Lead investments 3
Follow on index 0.42
Exits 4
Group Appearance index 0.89

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ryne Biotechnology

Biotechnology
Health Care
Medical
$82M29 Feb 2024 Cambridge, Massachusetts, United States

Generate Biomedicines

Biotechnology
$370M18 Nov 2021 Pennsylvania, United States

Repertoire Immune Medicines

Biotechnology
Life Science
Medical
Therapeutics
$189M13 Apr 2021 Cambridge, Massachusetts, United States

Tessera Therapeutics

Biopharma
Biotechnology
Therapeutics
$230M12 Jan 2021 Cambridge, Massachusetts, United States

Sana Biotechnology

Biotechnology
Health Care
Life Science
Product Research
$700M23 Jun 2020 Seattle, Washington, United States

Codiak Biosciences

Biotechnology
Medical
Therapeutics
$76M29 Nov 2017 San Francisco, California, United States

Generate Capital

Financial Services
Renewable Energy
Solar
Sustainability
$200M24 Oct 2017 San Francisco, California, United States

Denali Therapeutics

Biotechnology
Genetics
Health Diagnostics
Therapeutics
$130M25 Aug 2016 San Francisco, California, United States

Indigo

Agriculture
AgTech
Farming
GreenTech
$100M21 Jul 2016 Boston, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: